Management of Insomnia in Patients with Comorbid Conditions

Assessment and Treatment Approach

The American Academy of Sleep Medicine recommends evaluating sleep patterns using a sleep log to document sleep latency, number and duration of awakenings, wake time after sleep onset, total sleep time, and sleep efficiency 5
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for insomnia, with strong evidence for efficacy in chronic insomnia, according to the American College of Physicians 1, 6
CBT-I components should include sleep restriction therapy, stimulus control, cognitive therapy, and sleep hygiene education, as recommended by the American Academy of Sleep Medicine 7, 8, 5

The American Academy of Sleep Medicine suggests adding low-dose trazodone (25-50mg at bedtime) if CBT-I alone is insufficient, due to its efficacy for insomnia in patients on venlafaxine and lower risk of dependence compared to benzodiazepines or z-drugs 7, 8
Alternative options if trazodone is ineffective include low-dose doxepin (3-6mg), which has FDA approval for insomnia and minimal anticholinergic effects at low doses, as recommended by the American Academy of Sleep Medicine 7, 4

The American Academy of Sleep Medicine recommends reassessing sleep patterns using sleep logs after 2-4 weeks of intervention and evaluating for improvement in sleep efficiency, total sleep time, and daytime functioning 7, 5
If insomnia persists despite these interventions, consider referral to a sleep specialist for further evaluation, as suggested by the American Academy of Sleep Medicine 9

The American College of Physicians advises avoiding adding multiple sedating medications simultaneously, which increases risk of daytime sedation, and not relying solely on pharmacological management without addressing behavioral factors 8, 1, 10
Be cautious with long-term use of sedative-hypnotics, as they can lose efficacy over time and lead to dependence, according to the American College of Physicians 4